Lerotinib
PCD-DZ650-20-001
Phase 3 small_molecule active
Quick answer
Lerotinib for Esophageal Cancer is a Phase 3 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Esophageal Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active